Carla Castillo-Laborde
Overview
Explore the profile of Carla Castillo-Laborde including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
194
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hirmas-Adauy M, Castillo-Laborde C, Awad C, Jasmen A, Mattoli M, Molina X, et al.
Public Health Rev
. 2025 Jan;
45:1607756.
PMID: 39749218
Objectives: Comprehensively map and summarize digital health initiatives for the elderly and caregivers. Methods: Scoping review between April and May 2022 based on Joanna Briggs methodology. Databases used included PubMed,...
2.
Castillo-Laborde C, Matute I, Sgombich X, Jofre D
BMC Health Serv Res
. 2024 Nov;
24(1):1436.
PMID: 39563312
Background: Access to medicines is one of the most serious public health problems globally, and Chile is not an exception. The aim of this study was to explore patients' perceptions,...
3.
Matute I, Castillo-Laborde C
PLoS One
. 2024 Feb;
19(2):e0297807.
PMID: 38346084
Background: Access to medicines is a serious problem globally and in Chile. Despite the creation of coverage policies, part of the population with chronic conditions of high prevalence, still does...
4.
Peruga A, Castillo-Laborde C, Matute I, Molina X, Urrejola O, Aguilera X
Tob Induc Dis
. 2022 Nov;
20:96.
PMID: 36407939
Introduction: We tested if tobacco impressions were delivered differentially to prime-time TV watching minors by sex and socioeconomic status. Methods: Programs aired during prime-time for three random weeks in 2019...
5.
Castillo-Laborde C, Hirmas-Adauy M, Matute I, Jasmen A, Urrejola O, Molina X, et al.
Public Health Rev
. 2022 Sep;
43:1604796.
PMID: 36120091
Identify barriers and facilitators in access to medicines for diabetes, hypertension, and dyslipidemia, considering patient, health provider, and health system perspectives. Scoping review based on Joanna Briggs methodology. The search...
6.
SARS-CoV-2 Neutralizing Antibodies in Chile after a Vaccination Campaign with Five Different Schemes
Aguilera X, Hormazabal J, Vial C, Cortes L, Gonzalez C, Rubilar P, et al.
Vaccines (Basel)
. 2022 Jul;
10(7).
PMID: 35891215
Using levels of neutralizing antibodies (nAbs), we evaluate the successful Chilean SARS-CoV-2 vaccine campaign, which combines different vaccine technologies and heterologous boosters. From a population-based study performed in November 2021,...
7.
Aguilera X, Gonzalez C, Apablaza M, Rubilar P, Icaza G, Ramirez-Santana M, et al.
Vaccines (Basel)
. 2022 Jul;
10(7).
PMID: 35891166
Chile is among the most successful nations worldwide in terms of its COVID-19 vaccine rollout. By 31 December 2021, 84.1% of the population was fully vaccinated, and 56.1% received booster...
8.
Peruga A, Urrejola O, Delgado I, Matute I, Castillo-Laborde C, Molina X, et al.
Tob Control
. 2021 Oct;
32(3):323-329.
PMID: 34607886
Introduction: The extent of the population's exposure to tobacco imagery across all genres of regular TV programming and the contribution of each of these genres is unknown, except for UK...
9.
Castillo-Laborde C, de Wolff T, Gajardo P, Lecaros R, Olivar-Tost G, Ramirez C H
J Math Biol
. 2021 Sep;
83(4):42.
PMID: 34564787
Nonpharmaceutical interventions (NPI) such as banning public events or instituting lockdowns have been widely applied around the world to control the current COVID-19 pandemic. Typically, this type of intervention is...
10.
Castillo-Laborde C, Aguilera-Sanhueza X, Hirmas-Adauy M, Matute I, Delgado-Becerra I, Najera-De Ferrari M, et al.
MEDICC Rev
. 2021 Aug;
19(2-3):57.
PMID: 34352979
No abstract available.